Children, Infants & Newborns

This study will compare infant gut bacteria for infants who have been fed a standard infant formula (Enfamil Infant); infants who have been fed a new infant formula designed to be more similar to breast milk (Enfamil NeuroPro); and breastfed infants. These formulas are currently available on the market and meet FDA requirements for infant formula.

Primary disease category: 
Secondary disease category(ies): 

A Superiority Study to Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome

Primary disease category: 
Secondary disease category(ies): 

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is (DETECT)

Primary disease category: 
Secondary disease category(ies): 

This is a multi-center, open-label, single-arm study. All subjects will be pediatric patients with central precocious puberty judged to be candidates for GnRH (gonadotropin releasing hormone) analog therapy, and all will receive two injections of FP-001 42 mg six-month apart in an unblinded fashion.

Primary disease category: 
Secondary disease category(ies): 

The University of Arizona Division of Developmental & Behavioral Pediatrics has partnered with Axial Therapeutics for a clinical trial to determine whether its investigational drug, AB-2004, is safe and effective in treating the symptoms of autism spectrum disorder in children ages 5-17. This 12-week randomized, double-blind, placebo-controlled study includes behavioral assessments and safety monitoring. Blood draws, urine and stool samples are required.

Primary disease category: 
Secondary disease category(ies): 

The propose of this pilot study is to test the hypothesis that children with epilepsy have changes in gut microbiome as compared to their siblings and controls.

Our specific aims are:

1. To compare the taxonomy of gut microbiome in patients with new onset epilepsy versus siblings and controls. 

2. To compare the taxonomy of gut microbiome in patients with new onset epilepsy versus chronic and refractory epilepsy. 

Primary disease category: 

Parents or caregivers of a child with ADHD ages 6, 7 or 8 are invited to participate in a study to reduce ADHD symptoms. Parents are asked to complete surveys at two or three time points and to complete a six-week online course called the Nurtured Heart Approach.

Primary disease category: 
Secondary disease category(ies): 

We are looking for families with a child or adolescent with a diagnosis of type 1 diabetes to participate in a study examining the effects of an intervention to assist families with their daily routines. Assessments and the intervention consultation address sleep, school, and family activities that may help or interfere with diabetes management.

Primary disease category: 
Secondary disease category(ies): 

We plan to study a cohort of children with central lines placed to determine who is at high risk for thrombotic event.

Primary disease category: 

Pages

Subscribe to RSS - Children, Infants & Newborns